- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x RET: RETINAL(Covalent)
- 18 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.3: 10 residues within 4Å:- Chain A: R.213, V.214, F.217, L.221, F.228, P.266, I.267, I.270, G.275, F.276
Ligand excluded by PLIPOLC.4: 8 residues within 4Å:- Chain A: V.212, F.216, M.219
- Chain B: I.131, I.134, I.135
- Ligands: OLC.7, OLC.21
Ligand excluded by PLIPOLC.5: 3 residues within 4Å:- Chain A: A.86, L.89, A.90
Ligand excluded by PLIPOLC.6: 4 residues within 4Å:- Chain A: Y.223, Y.226
- Chain B: W.120
- Ligands: OLC.21
Ligand excluded by PLIPOLC.7: 10 residues within 4Å:- Chain A: Y.211, V.212, F.216
- Chain B: I.135, H.139, E.143, P.144, A.145, L.158
- Ligands: OLC.4
Ligand excluded by PLIPOLC.8: 4 residues within 4Å:- Chain A: A.232, I.236, Y.239
- Ligands: OLC.11
Ligand excluded by PLIPOLC.9: 2 residues within 4Å:- Chain A: F.228, A.232
Ligand excluded by PLIPOLC.10: 7 residues within 4Å:- Chain A: Y.124, T.127, I.131
- Chain B: M.219, Y.223
- Ligands: OLC.15, OLC.17
Ligand excluded by PLIPOLC.11: 2 residues within 4Å:- Chain A: W.256
- Ligands: OLC.8
Ligand excluded by PLIPOLC.14: 10 residues within 4Å:- Chain B: R.213, V.214, F.217, L.221, F.228, P.266, I.267, I.270, G.275, F.276
Ligand excluded by PLIPOLC.15: 8 residues within 4Å:- Chain A: I.131, I.134, I.135
- Chain B: V.212, F.216, M.219
- Ligands: OLC.10, OLC.18
Ligand excluded by PLIPOLC.16: 3 residues within 4Å:- Chain B: A.86, L.89, A.90
Ligand excluded by PLIPOLC.17: 4 residues within 4Å:- Chain A: W.120
- Chain B: Y.223, Y.226
- Ligands: OLC.10
Ligand excluded by PLIPOLC.18: 10 residues within 4Å:- Chain A: I.135, H.139, E.143, P.144, A.145, L.158
- Chain B: Y.211, V.212, F.216
- Ligands: OLC.15
Ligand excluded by PLIPOLC.19: 4 residues within 4Å:- Chain B: A.232, I.236, Y.239
- Ligands: OLC.22
Ligand excluded by PLIPOLC.20: 2 residues within 4Å:- Chain B: F.228, A.232
Ligand excluded by PLIPOLC.21: 7 residues within 4Å:- Chain A: M.219, Y.223
- Chain B: Y.124, T.127, I.131
- Ligands: OLC.4, OLC.6
Ligand excluded by PLIPOLC.22: 2 residues within 4Å:- Chain B: W.256
- Ligands: OLC.19
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Oda, K. et al., Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin. Elife (2021)
- Release Date
- 2021-04-07
- Peptides
- Archaeal-type opsin 1,Archaeal-type opsin 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x RET: RETINAL(Covalent)
- 18 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Oda, K. et al., Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin. Elife (2021)
- Release Date
- 2021-04-07
- Peptides
- Archaeal-type opsin 1,Archaeal-type opsin 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A - Membrane
-
We predict this structure to be a membrane protein.